Se. Fathalla et al., EPSTEIN-BARR-VIRUS (EBV) ANTIBODY PATTERNS AMONG THE HEALTHY POPULATION AND THE EBV-ASSOCIATED PATIENTS IN EASTERN SAUDI-ARABIA (1990-1994), Saudi medical journal, 17(5), 1996, pp. 608-613
Objective: 1 - Seroepidemiological survey for EBV prevalence in Easter
n Saudi Arabia. 2 - To expose the different EBV antibody patterns amon
g healthy population and EBV-associated disease patients. Design: For
detection of EBV antibodies (EA IgM, EA IgG, EBNA IgG and VCA IgG), we
used regular classical ELISAs, re-DNA and synthetic polypeptides ELIS
A, also, Immunofluorescence technique IIFT. Setting: In virology-diagn
ostic laboratory of Dammam Regional Labs & Blood-Bank. Subjects: One t
housand seven hundred and eighty-three blood specimens including healt
hy population (of different ages), and EBV-associated disease patients
.Results: 1-EBV incidence showed 80%, 61.8%, 82.6% and 96.4% among hea
lthy blood donors. Healthy children, healthy pregnant women, and EBV-A
ssociated patients respectively. 2 - The incidence among children (dif
ferent age-groups): 44.4%, 55.7%, 62.5%, and 72.3% for the < 6, < 12,
< 15 and < 18 year-age group respectively. 3 - EBV-healthy pattern: 69
.17% showed a pattern: (EA IgM-, EA IgG-, EBNA IgG+ and VCA IgG variab
le), while 18.33% were negative. 4-EBV associated patients: Very early
pattern: EA IgM+, EA IgG EBNA IgG- Early pattern: EA IgM+, EA IgG+, E
BNA variable, VCA+. Convalescence pattern: EA IgM-, EA IgG+, EBNA-, VC
A+. Latent pattern: EA IgM-, EA IgG variable, EBNA+, VCA variable. Lif
e long latency pattern: EA IgM-, EA Ige-, EBNA+, VCA Ige variable. Con
clusion: EBV is circulating in this part of the world as elsewhere, an
d the EA IgM, EA IgG are of prime diagnostic importance for the primar
y infection, while the EBNA IgG parameter is excellent for the epidemi
ological studies. However, the VCA Ige appeared to be of less importan
ce as either a diagnostic or epidemiological marker. We recommend furt
her follow-up for healthy EBV negative subjects in cases of possible o
rgan transplantation (who also must be an EBV negative donor).